RecruitingEarly Phase 1ketamine

Ketamine and Propofol NeuroImaging

Sponsored by Keith M Vogt

NCT ID
NCT07294092
Target Enrollment
60 participants
Start Date
2026-04-30
Est. Completion
2028-08-02

About This Study

This is a multi-visit which will collect MRI (pictures of the brain) and EEG (brain waves) data to determine changes in brain connectivity and brain activity for memory formation and pain perception while receiving the commonly-used anesthetic agents ketamine and propofol, both alone and in combination.

Conditions Studied

AnesthesiaPain

Interventions

  • Propofol
  • Ketamine
  • Peripheral Nerve Stimulation

Eligibility

Age:18 Years - 59 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Adults 18-59 years of age, who:
* have none of the specific exclusion criteria
* have a valid email address and valid phone number throughout the study
* free from any non-MRI compatible implants

Exclusion Criteria:

* are pregnant or attempting to conceive
* body mass index (BMI) \> 35
* significant memory impairment or hearing loss
* sleep apnea
* chronic pain or frequently taking pain medication
* chronic medical conditions requiring treatment (hypertension, diabetes, high cholesterol)
* neurologic disease, including seizures and tremor
* psychiatric diagnoses, including anxiety, depression, panic, or PTSD
* a history of any of these medical conditions: abnormal heartbeats (cardiac conduction abnormality or arrhythmia), liver or kidney disease, or significant lung disease
* severe claustrophobia or intolerance of an MRI
* have metal implants or non-removable metal piercings
* having a history of adverse reaction to ketamine or propofol
* daily alcohol or heavy alcohol use; history of alcohol abuse
* current daily smoker
* regular or recent marijuana use (including prescribed/medical marijuana)
* illicit drug use, i.e., street drugs
* regularly taking: antiepileptics, antidepressants, anti-psychotics, antihistamines, anti-anxiety medication, stimulants, or sleep-aids

Study Locations (1)

University of Pittsburgh
Pittsburgh, Pennsylvania, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Keith M Vogt, MD, PhD
CONTACT
4126473147kev18@pitt.edu
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source